Skip to main content

Table 1 Standardized incidence rates (SIR) analysis with 95 % confidence intervals (CI) for cancer (overall and the six most prevalent sites) in the cohort compared to the general male population in Oslo and Akershus

From: Cholesterol and prostate cancer risk: a long-term prospective cohort study

  Observed Expected SIR (95 % CI)
Cancer, overall 758 798.3 0.95 (0.88–1.02)
Colon 87 81.9 1.06 (0.86–1.31)
Rectum 44 47.4 0.93 (0.69–1.25)
Lung 109 126.0 0.86 (0.72–1.04)
Prostate 213 201.7 1.06 (0.92–1.21)
Bladder and kidney 104 100.7 1.03 (0.85–1.25)
Melanoma 94 83.7 1.12 (0.92–1.37)